New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Relay Therapeutics, Inc.
RLAY
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

1B

Biotechnology

Next Earning date - 07 Nov 2024

1B

Biotechnology

Next Earning date - 07 Nov 2024

6.66USD
Shape0.23 ( 3.58%)
favorite-chart

Relative Strenght

9
favorite-chart

Volume Buzz

-52%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

45%

Quote Panel

Shape
Updated October 23, 2024
1W 0.15 % 1M -8.78 % 3M -25.53 % 1Y 5.56 %

Key Metrics

Shape
  • Market Cap

    1.08B


  • Shares Outstanding

    162.46M


  • Share in Float

    120.66M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    6.66


  • Average Volume

    1.93M


  • Beta

    1.646


  • Range

    5.7-12.14


  • Industry

    Biotechnology


  • Website

    https://www.relaytx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

30.73x

P/S Ratio

1.30x

P/B Ratio

0.1

Debt/Equity

-916.9%

Net Margin

$-2.5

EPS

How RLAY compares to sector?

P/E Ratio

Relative Strength

Shape

RLAY

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$608K

ShapeNaN%

2025-Revenue

$3.16

Shape-358%

2025-EPS

$320K

Shape100%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Oppenheimer

downgrade

Previous: Buy

2024-09-09

Now: Perform

Citigroup

upgrade

Previous: Buy

2023-04-20

Now: Overweight

Piper Sandler

downgrade

Previous: Not converted

2023-04-20

Now: Neutral

Wolfe Research

downgrade

Previous: Not converted

2023-04-20

Now: Underperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.76
vs -0.66

Q4.22

arrow
arrow

N/A

-0.56
vs 0.36

Q1.23

arrow
arrow

N/A

-0.78
vs -0.61

Q2.23

arrow
arrow

N/A

-0.81
vs -0.71

Q3.23

arrow
arrow

N/A

-0.54
vs -0.76

Q4.23

arrow
arrow

N/A

-0.67
vs -0.56

Q1.24

arrow
arrow

N/A

-0.62
vs -0.78

Q2.24

arrow
arrow

N/A

-0.69
vs -0.81

Q3.24

arrow
arrow

N/A

-0.77
vs -0.54

Q4.24

arrow
arrow

N/A

-0.75
vs -0.67

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-48%

344K  vs 666K

Q4.22

arrow
arrow

-55%

253K  vs 567K

Q1.23

arrow
arrow

-46%

226K  vs 419K

Q2.23

arrow
arrow

-67%

119K  vs 365K

Q3.23

arrow
arrow

+7226%

25.2M  vs 344K

Q4.23

arrow
arrow

-100%

-1000.00  vs 253K

Q1.24

arrow
arrow

+4328%

10M  vs 226K

Q2.24

arrow
arrow

-100%

NA  vs 119K

Q3.24

arrow
arrow

-100%

88.9K  vs 25.2M

Q4.24

arrow
arrow

+8989%

88.9K  vs -1000

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-9%

-0.09
vs -0.10

Q4.22

arrow
arrow

-5%

-0.05
vs -0.09

Q1.23

arrow
arrow

-10%

-0.10
vs -0.05

Q2.23

arrow
arrow

-12%

-0.12
vs -0.10

Q3.23

arrow
arrow

-8%

-0.08
vs -0.12

Q4.23

arrow
arrow

-11%

-0.11
vs -0.08

Q1.24

arrow
arrow

-11%

-0.11
vs -0.11

Q2.24

arrow
arrow

-14%

-0.14
vs -0.11

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

155

155
vs 139

12%

Q4.22

arrow
arrow

166

166
vs 155

7%

Q1.23

arrow
arrow

162

162
vs 166

-2%

Q2.23

arrow
arrow

165

165
vs 162

2%

Q3.23

arrow
arrow

171

171
vs 165

4%

Q4.23

arrow
arrow

176

176
vs 171

3%

Q1.24

arrow
arrow

186

186
vs 176

6%

Q2.24

arrow
arrow

178

178
vs 186

-4%

Earnings Growth

Latest News